Wire · founder news, decoded · opportunities
Real Chemistry builds body of AI tools with Anatomi launch
Real Chemistry launches Anatomi, a suite of AI tools purpose-built for healthcare commercialization, integrating LLMs and proprietary data across marketing, medical affairs, and regulatory workflows. The move positions the agency to compete against generalist AI platforms and client in-house capabilities by embedding healthcare-specific compliance and therapeutic knowledge.
This Wire brief sits within Fusion42's coverage of Digital Health. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur, Fusion42's AI co-founder, reasons over.
The Wire takeaway
If you're building AI for healthcare marketing or comms, Real Chemistry just showed that agencies will own the distribution layer by embedding regulatory knowledge into their tools. Your buyers now need to choose between licensing your AI or buying a Real Chemistry seat.
Read the full story at fiercepharma.com →
Topics: Digital Health · ai-tools · pharma-marketing · healthcare-compliance · agency-tech · commercialization